Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio Gets CE-IVD Mark for SARS-CoV-2 Test

NEW YORK — Takara Bio Europe said on Tuesday that it has received CE-IVD marking for an RT-qPCR-based test for the detection of SARS-CoV-2.

The Takara SARS-CoV-2 Direct PCR detection kit is designed to detect regions of the SARS-CoV-2 nucleocapsid genes in nasopharyngeal or nasal swab samples, as well as crude saliva samples. It does not require RNA extraction and provides results within 60 minutes, the company said.

The test was approved in Japan last year, Takara Bio Europe said.

Takara Bio Europe is a French subsidiary of Japan's Takara Bio.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.